We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-5.2%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.55B
AUM Growth
-$395M
Cap. Flow
+$563M
Cap. Flow %
15.85%
Top 10 Hldgs %
43.38%
Holding
114
New
26
Increased
23
Reduced
23
Closed
40

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$187M
2
PFE icon
Pfizer
PFE
+$168M
3
GILD icon
Gilead Sciences
GILD
+$125M
4
UNH icon
UnitedHealth
UNH
+$125M
5
LLY icon
Eli Lilly
LLY
+$93.4M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$84.3M
2
AAPL icon
Apple
AAPL
+$80.7M
3
BRCM
BROADCOM CORP CL-A
BRCM
+$75.5M
4
LBTYK icon
Liberty Global Class C
LBTYK
+$74M
5
VMW
VMware, Inc
VMW
+$72.2M

Sector Composition

Rank Sector Weight
1 Healthcare 59.47%
2 Communication Services 6.34%
3 Financials 5.66%
4 Technology 4.95%
5 Consumer Discretionary 4.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FBIN icon
26
Fortune Brands Innovations
FBIN
$6.23B
$48.3M 1.36%
+1,191,220
New +$49.1M
ALLY icon
27
Ally Financial
ALLY
$13.3B
$47.9M 1.35%
2,348,383
+1,377,572
+142% +$29.9M
MA icon
28
Mastercard
MA
$496B
$45.1M 1.27%
+500,093
New +$47M
JD icon
29
JD.com
JD
$43B
$44.1M 1.24%
1,693,324
+362,193
+27% +$10.5M
JAZZ icon
30
Jazz Pharmaceuticals
JAZZ
$16.3B
$43.3M 1.22%
326,002
-139,412
-30% -$24M
GOOG icon
31
Alphabet (Google) Class C
GOOG
$4.06T
$42.3M 1.19%
+1,326,200
New +$40.8M
EXP icon
32
Eagle Materials
EXP
$6.9B
$40.1M 1.13%
586,800
-418,939
-42% -$32.7M
RDUS
33
DELISTED
Radius Health, Inc.
RDUS
$40M 1.13%
577,034
-186,262
-24% -$12.9M
AERI
34
DELISTED
Aerie Pharmaceuticals
AERI
$39.4M 1.11%
2,218,198
+366,634
+20% +$6.64M
MTG icon
35
MGIC Investment
MTG
$6.44B
$38M 1.07%
4,104,737
-835,000
-17% -$8.85M
KITE
36
DELISTED
Kite Pharma, Inc.
KITE
$38M 1.07%
682,577
+373,425
+121% +$23.5M
ALDR
37
DELISTED
Alder Biopharmaceuticals
ALDR
$36.2M 1.02%
1,105,911
+352,630
+47% +$15M
HUM icon
38
Humana
HUM
$45.8B
$33.5M 0.94%
186,935
-256,128
-58% -$47.3M
GBT
39
DELISTED
Global Blood Therapeutics, Inc.
GBT
$32M 0.9%
+758,816
New +$35.8M
LNKD
40
DELISTED
LinkedIn Corporation
LNKD
$28.9M 0.81%
151,848
-78,597
-34% -$15.6M
ARAY icon
41
Accuray
ARAY
$29.3M
$28.8M 0.81%
5,771,250
+1,342,989
+30% +$8.63M
NFLX icon
42
Netflix
NFLX
$305B
$27.9M 0.79%
2,706,330
+572,590
+27% +$6.15M
LBTYK icon
43
Liberty Global Class C
LBTYK
$3.31B
$27.9M 0.79%
784,471
-1,830,857
-70% -$74M
THOR
44
DELISTED
THORATEC CORPORATION
THOR
$27.4M 0.77%
432,577
-297,497
-41% -$17.7M
AIMT
45
DELISTED
Aimmune Therapeutics
AIMT
$25.2M 0.71%
+996,112
New +$23.3M
ACOR
46
DELISTED
Acorda Therapeutics
ACOR
$24.2M 0.68%
7,614
+802
+12% +$3.11M
RAD
47
DELISTED
Rite Aid Corporation
RAD
$21.8M 0.61%
179,164
-101,766
-36% -$17M
BPMC
48
DELISTED
Blueprint Medicines
BPMC
$21M 0.59%
1,027,553
+165,388
+19% +$4.57M
MOH icon
49
Molina Healthcare
MOH
$10.2B
$15.7M 0.44%
228,635
+61,401
+37% +$4.55M
PEN icon
50
Penumbra
PEN
$12.6B
$15.3M 0.43%
+381,270
New +$15.4M
1
2
3 4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q3 2015 Portfolio in Review

As of Q3 2015, PFM Health Sciences held 114 positions worth $3.55B, down 10% from $3.95B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

PFM Health Sciences deployed $563M of net new capital in Q3 2015, opening 26 new positions and adding to 23 existing holdings. Its largest new stake was Allergan plc: 608,789 shares worth $165M.

By sector, the portfolio is most concentrated in Healthcare at 59% of assets, up from 48% a quarter earlier, followed by Communication Services and Financials.

On the sell side, the largest reduction was BROADCOM CORP CL-A, an estimated $75.5M trimmed.

  • PFM Health Sciences's largest Q3 2015 buy was Allergan plc: 608,789 shares worth $165M.
  • PFM Health Sciences added most to Pfizer in Q3 2015, an estimated $168M increase.
  • PFM Health Sciences's biggest Q3 2015 reduction was BROADCOM CORP CL-A, cutting an estimated $75.5M.
  • PFM Health Sciences fully exited Elevance Health in Q3 2015, selling an estimated $84.3M.
  • PFM Health Sciences's ten largest holdings make up 43% of its $3.55B portfolio in Q3 2015.
  • PFM Health Sciences opened 26 new positions and closed 40 in Q3 2015.
  • PFM Health Sciences's portfolio value fell 10% quarter-over-quarter to $3.55B.

Based on PFM Health Sciences's 13F filing for Q3 2015, filed 16 Nov 2015.